slavemotion / iStockphoto.com
18 July 2017Big Pharma
European Commission calls out Teva over anti-competitive practice
The European Commission has called out Teva over anti-competitive behaviour centring on a pay-for-delay drug deal.
Already registered?
Login to your account
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
Europe
15 March 2018 Israeli pharmaceutical company Teva “robustly” responded to the European Commission’s charge of anti-competitive behaviour at a hearing earlier this week.
Europe
9 July 2020 Drug company Teva has lost an appeal over its bid to trademark two word signs, after the tenth chamber of the EU General Court ruled in favour of the European Union IP Office (EUIPO) yesterday, July 8.
Editor's picks
Editor's picks
Europe
15 March 2018 Israeli pharmaceutical company Teva “robustly” responded to the European Commission’s charge of anti-competitive behaviour at a hearing earlier this week.
Europe
9 July 2020 Drug company Teva has lost an appeal over its bid to trademark two word signs, after the tenth chamber of the EU General Court ruled in favour of the European Union IP Office (EUIPO) yesterday, July 8.
Europe
15 March 2018 Israeli pharmaceutical company Teva “robustly” responded to the European Commission’s charge of anti-competitive behaviour at a hearing earlier this week.
Europe
9 July 2020 Drug company Teva has lost an appeal over its bid to trademark two word signs, after the tenth chamber of the EU General Court ruled in favour of the European Union IP Office (EUIPO) yesterday, July 8.